January 2018
Formal pharmaceutical R&D and production-based partnership between Acceledev and China based Suli Pharmaceutical Technology Jiangyin Co., Ltd. announced.
January 2020
AcceleDev proudly achieves its 7th consecutive Ecovadis awards for Corporate Social Responsibility, including 21 criteria across four themes of Environment, Fair labor & human rights, ethics, and sustainable procurement.
April 2020
AcceleDev announces a major commercial production expansion of its 2nd RSM site, Hubei SeaGate Pharma Science Ltd. Our Haimen Seagate site had been operating at 100% full capacity for 4 consecutive years.
June 2020
Acceledev was called-on to provide urgent support to a wide range of rapid development Covid-19 programs, including first approved Pfizer-BioNTech vaccine, Comirnaty. We are proud of the trust our customers have in our team, to help them develop and commercially supply under extremely tight timelines.